Patent · US Active

MDL-1 ligand

US9284377B2 · kind B2 · utility

0Cited by
0References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 19, 2015
Grant dateMar 15, 2016
Priority date
Expiry dateJun 19, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/10
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention provides methods for modulation interactions between MDL-1 and its binding partner, Gal9. Also provided are methods to screen for modulators of MDL-1/Gal9 interaction.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.